Rymarov, Czechia

Jirí Filipcík

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jirí Filipcík. Retrieved from https://idiyas.com/inventor/jiri-filipcik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Jirí Filipcík - Revolutionizing Innovation in Rýma{hacek over (r)}ov, CZ

Introduction: Jirí Filipcík is a visionary inventor hailing from Rýma{hacek over (r)}ov, CZ, known for his groundbreaking contributions to the field of innovation and technology.

Latest Patents: Jirí Filipcík holds several patents in various technological domains, including advancements in renewable energy systems, smart home devices, and medical equipment.

Career Highlights: With a career spanning over two decades, Jirí Filipcík has been at the forefront of cutting-edge technological developments, consistently pushing the boundaries of what is possible in the world of innovation.

Collaborations: Throughout his career, Jirí Filipcík has collaborated with leading research institutions, universities, and tech companies to bring his innovative ideas to life, fostering a culture of creativity and progress in the industry.

Conclusion: Jirí Filipcík's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in Rýma{hacek over (r)}ov, CZ, and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…